O’Quinn firm faces suit over expenses 
Published: January 7, 2013
Tags: breach of contract, breach of fiduciary duty, deceptive trade practices, ethics, fraud, legal ethics, mass tort, negligence, referral fees, settlements, silicosis litigation
According to a lawsuit filed by former clients, the Texas-based O’Quinn law firm mishandled their silicosis litigation settlement funds.
Plaintiffs sue food companies over ‘all natural’ claims
By:
Correy Stephenson
Published: April 5, 2012
Tags: class action, consumer fraud, deceptive trade practices, false advertising, misrepresentation
A number of recent lawsuits filed by plaintiffs allege that companies are falsely advertising their products as “all natural” or “100 percent” natural when they in fact contain synthetic ingredients or genetically modified organisms.
StubHub can’t be sued for scalping tickets
Published: March 22, 2012
Tags: Communications Decency Act, consumer protection, deceptive trade practices
Federal law immunizes StubHub from a state lawsuit alleging that the online ticket company engaged in unfair or deceptive trade practices by scalping tickets, the North Carolina Court of Appeals has ruled in reversing a summary judgment.
Small firm wins $3.4 million against doctor’s insurer
By:
Sylvia Hsieh
Published: September 1, 2011
Tags: breach of contract, deceptive trade practices, insurance, medical malpractice
After winning a $22 million medical malpractice verdict on behalf of a young man who went into the hospital complaining of neck pain and left paralyzed from the waist down, lawyers for the man won a $3.4 million verdict last month in a companion case against a doctor’s insurance company for not covering the malpractice award.
Judge orders maker of Risperdal to pay $327 million
Published: June 27, 2011
Tags: deceptive trade practices, drug marketing, Johnson & Johnson, Ortho-McNeil Pharmaceutical, Ortho-McNeil-Janssen Pharmaceutica, prescription drugs, Risperdal
A judge has ordered the maker of Risperdal to pay $327 million in civil penalties to the state of South Carolina for its marketing of the antipsychotic drug.
Hormone drug plaintiffs must show reliance
By:
Pat Murphy
Published: January 3, 2011
Tags: consumer protection, deceptive trade practices, hormone replacement therapy, product liability, reliance, Wyeth
Consumers must show detrimental reliance in order to hold a drug manufacturer liable for misleading statements in its marketing of hormone replacement therapy drugs, West Virginia’s highest court has ruled.
Two states sue Bank of America over loan modifications
By:
Sylvia Hsieh
Published: December 28, 2010
Tags: Bank of America, deceptive trade practices, foreclosures, loan modification
Arizona and Nevada have sued Bank of America alleging deceptive trade practices in the way they have handled mortgage loan modifications and foreclosures.
Marketing suit against Nexium thrown out
By:
Sylvia Hsieh
Published: November 10, 2009
Tags: AstraZeneca, deceptive trade practices, false marketing, FDA, Nexium, Prilosec
Drug maker AstraZeneca can’t be sued for allegedly falsely marketing Nexium as “new” and “better” than Prilosec even though the two drugs were very similar, because the FDA approved its labeling, the Arkansas Supreme Court has ruled.
Nutritional company to pay distributors $1.8 million
By:
Nora Tooher
Published: September 8, 2009
Tags: deceptive trade practices
A Dallas jury has ordered Texas-based Advocare International to pay $1.8 million for unfairly ending its agreement with a couple who had built a lucrative distributorship selling the company’s nutritional supplements and wellness products.
